of Company Secretary, the Establishment of New Subsidiary and Subsidiary to Purchase Drug Care Company Limited (Revise no. 2) 10/11/2021 09:27 Notification of the resignation of Chairman of the Audit

Committee, Appointment of Audit Committee, Appointment of Company Secretary, the Establishment of New Subsidiary and Subsidiary to Purchase Drug Care Company Limited (Revise no. 2) 10/11/2021 09:27

the issuer’s core business. In any event, the issuer must not operate business in such a way that involves severely illegal business. For example, human trafficking, drug production or smuggling, or

involves severely illegal business. For example, human trafficking, drug smuggling or money laundering etc. Moreover, the issuer must not act in violation or non-compliance with the law, which may cause

issuance to lock in their funding cost before any rate increase. Meanwhile, long-term bond yields moved within a narrow range amid heightened risks in emerging markets and escalating trade tension between

service, emphasizing on convenience, simplicity, and worry-free to use mobile data. Competition in fixed broadband has been heightened by the incumbents. Although an average industry ARPU remained in a

operations and exposures in commodities • Impairment issues • Heightened cost controls at audit clients • Governance challenges (cannot get or retain strong directors) Layoffs Reduced  capacity Audit fee

Heightened Engagement? ....................................................... 37 Top US Legal Considerations Regarding Shareholder and Issuer Engagements ........................................... 38

system of new medicines according to the additional standards SET forth by the Food and Drug administration. Therefore, it is necessary to use the capital to proceed the project amount 32,000,000 baht

recognition Drug license Manufacturing service (OEM) Contracts with a customer ▪ บรษัิทยาท าสญัญาขายทะเบยีนต ารับยาทีไ่ดข้ ึน้ ทะเบยีนยากบั อย. แลว้ ใหล้กูคา้ ▪ ลกูคา้ยังไมไ่ดรั้บโอน ทะเบยีนต ารับยาตาม กฎหมาย